David E. Lanfear
Impact in
- Family Practice top 0.5%
- Medication Adherence and Compliance
-
- Heart Failure Treatment and Management
- Cardiomyopathy and Myosin Studies
Papers in
-
- Heart Failure Treatment and Management 82
- Acute Myocardial Infarction Research 14
- Pharmacology 21
- Pharmacogenetics and Drug Metabolism 20
- Co-authors
- L. Keoki Williams (32 shared papers)Karen E. Wells (19 shared papers)Edward L. Peterson (25 shared papers)Celeste T. Williams (26 shared papers)John A. Spertus (25 shared papers)Robert J. Brewer (16 shared papers)Manel Pladevall (7 shared papers)Hassan W. Nemeh (18 shared papers)
- Journals
- Journal of Cardiac Failure (28 papers)The Journal of Heart and Lung Transplantation (17 papers)Circulation Heart Failure (12 papers)Journal of the American College of Cardiology (9 papers)JACC Heart Failure (9 papers)
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
David E. Lanfear
202 papers receiving 6.1k citations
David E. Lanfear's Hit Papers
Peers
Comparison fields: 5 of 125
- Family Practice 293
- Cardiology and Cardiovascular Medicine 2.6k
- Pharmacology 352
- Biomedical Engineering 975
- Endocrinology, Diabetes and Metabolism 432
Countries citing papers authored by David E. Lanfear
This map shows the geographic impact of David E. Lanfear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Lanfear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Lanfear more than expected).
Fields of papers citing papers by David E. Lanfear
This network shows the impact of papers produced by David E. Lanfear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Lanfear. The network helps show where David E. Lanfear may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Lanfear, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 209 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure Hit paper breakdown → | 2020 | 481 |
| 2 | Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction Hit paper breakdown → | 2019 | 343 |
| 3 | 2011 | 294 | |
| 4 | Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association Hit paper breakdown → | 2016 | 269 |
| 5 | The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial Hit paper breakdown → | 2022 | 190 |
| 6 | 2005 | 149 | |
| 7 | 2007 | 143 | |
| 8 | 2012 | 131 | |
| 9 | 2014 | 120 | |
| 10 | 2009 | 118 | |
| 11 | 2021 | 108 | |
| 12 | 2008 | 105 | |
| 13 | 2013 | 101 | |
| 14 | 2017 | 90 | |
| 15 | 2016 | 88 | |
| 16 | 2022 | 79 | |
| 17 | 2014 | 77 | |
| 18 | 2022 | 77 | |
| 19 | 2018 | 75 | |
| 20 | 2017 | 72 |
About David E. Lanfear
David E. Lanfear is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology, Biomedical Engineering, Genetics and Physiology, having authored 209 papers that have together received 6.4k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (82 papers), Mechanical Circulatory Support Devices (48 papers), Genetic Associations and Epidemiology (28 papers), Pharmacogenetics and Drug Metabolism (20 papers), Acute Myocardial Infarction Research (14 papers), Asthma and respiratory diseases (10 papers), Cardiovascular and exercise physiology (6 papers) and Medication Adherence and Compliance (4 papers). The work is most often cited by research in Family Practice (293 citations), Cardiology and Cardiovascular Medicine (2.6k citations), Pharmacology (352 citations), Biomedical Engineering (975 citations) and Endocrinology, Diabetes and Metabolism (432 citations). David E. Lanfear has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include L. Keoki Williams, Karen E. Wells, Edward L. Peterson, Celeste T. Williams, John A. Spertus, Robert J. Brewer, Manel Pladevall, Hassan W. Nemeh, Jeffrey A. Morgan and Cristina Tita. Their work appears in journals such as Journal of Cardiac Failure, The Journal of Heart and Lung Transplantation, Circulation Heart Failure, Journal of the American College of Cardiology and JACC Heart Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.